Improving Artemisinic Acid Production in Engineered Yeast
Author Information
Author(s): Ro Dae-Kyun, Ouellet Mario, Paradise Eric M, Burd Helcio, Eng Diana, Paddon Chris J, Newman Jack D, Keasling Jay D
Primary Institution: University of Calgary
Hypothesis
Can the production of artemisinic acid in engineered yeast be improved by altering plasmid selection markers and culture conditions?
Conclusion
The study found that modifying the plasmid selection marker and culture medium significantly increased artemisinic acid production in engineered yeast.
Supporting Evidence
- The engineered yeast produced 250 μg mL-1 of artemisinic acid in shake-flask cultures.
- Using a high-copy plasmid system increased artemisinic acid production by 8.1-fold.
- Induction of pleiotropic drug resistance genes was observed in yeast producing artemisinic acid.
Takeaway
Scientists made yeast that can produce a medicine for malaria, and they found ways to make it produce even more of the medicine by changing how they grow the yeast.
Methodology
The study involved engineering yeast to express plant genes for artemisinic acid production and analyzing the effects of plasmid stability and culture conditions on production levels.
Potential Biases
Potential bias in the selection of plasmid systems and culture conditions that may not represent all possible configurations.
Limitations
The study did not optimize all possible conditions for maximum yield, and the effects of unmeasured variables on production were not fully explored.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website